[en] A combined mexiletine and amiodarone treatment was applied in nine cases with recurrent refractory ventricular tachycardia. During the first two days of treatment, mexiletine and amiodarone were perfused intravenously at a dose of 1,000 mg. and 1,500 mg. per 24 hours, respectively. Simultaneously amiodarone was also given orally at a dose of 600 mg. per 24 hours. From the third day onwards, the intravenous administration was interrupted and both drugs were continued orally at a dose of 600 mg. daily. The first three patients were very critically ill and had had at least five episodes of ventricular tachycardia per 24 hours during the last 10 days in the intensive care unit. The treatment resulted in total suppression of the tachycardic episodes within three days after initiation of therapy. In the remaining six cases, ventricular tachycardia was easily initiated by programmed electrical stimulation of the heart. No arrhythmia could be elicited by repeated testing on the seventh day of treatment. The mean follow-up period was 6 months. Two patients with poor left ventricular function died in intractable heart failure. Another one died suddenly 4-1/2 months after his release from the hospital. He had a large aneurysm and whether he continued his treatment is unknown. A fourth patient had an aneurysmectomy; he suffered a recurrence, and died at his second operation. All the others presently remain asymptomatic. The association of a class I (mexiletine) with a class III (amiodarone) agent is theoretically attractive for the treatment of refractory ventricular arrhythmias. The present findings corroborate this hypothesis, but show that this association is not able to protect individuals with severe underlying myocardial damage.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Waleffe, A.
Mary-Rabine, L.
Legrand, Victor ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie
Demoulin, J. C.
Kulbertus, Henri ; Université de Liège - ULiège > Relations académiques et scientifiques (Médecine)
Language :
English
Title :
Combined mexiletine and amiodarone treatment of refractory recurrent ventricular tachycardia.
Waleffe, Bruninx, Mary-Rabine, Kulbertus (1979) Effects of tocainide studied with programmed electrical stimulation of the heart in patients with reentrant arrhythmias. Am. J. Cardiol. 43:292.
Zipes (1978) Symposium on new aspects of antiarrhythmic therapy. Introduction: Miles to go. Am. J. Cardiol. 41:975.
Vaughan-Williams (1977) Mexiletine in isolated tissue models. Postgrad. Med. J. 53:30.
Wittig, Harrison, Wallace (1977) Electrophysiological effects of lidocaine on distal Purkinje fibers of canine heart. Am. Heart J. 86:69.
Paalman, Roos, Siebelink, Dunning (1977) Development of a dosage scheme for simultaneous intravenous and oral administration of mexiletine. Postgrad. Med. J. 53:128.
Zipes, Troup (1978) New antiarrhythmic agents: amiodarone, aprindine, disopyramide, ethmozin, mexiletine, tocainide, verapamil. Am. J. Cardiol. 41:1005.
Kennel, Sorlie, MacNamara (1979) Prognosis after initial myocardial infarction: The Framingham study. Am. J. Cardiol. 44:58.
Winkle, Alderman, Fitzgerald, Harrison (1976) Treatment of symptomatic ventricular tachycardia. Ann. Intern. Med. 85:1.
Wu, Windham, Denes, Amat-y-Leon, Miller, Dhingra, Rosen (1977) Chronic electrophysiologic study in patients with recurrent paroxysmal tachycardia; a new method for developing successful oral antiarrhythmic therapy. Reentrant Arrhythmias, Mechanisms and Treatment, H.E. Kulbertus, MTP, Lancaster; .
Fisher, Cohen, Mehra, Actschuler, Escher, Furman (1977) Cardiac pacing and pacemakers. II. Serial electrophysiologic-pharmacologic testing for control of recurrent tachyarrhythmias. Am. Heart J. 83:658.
Horowitz, Josephson, Farshidi, Spielman, Michelson, Greenspan (1978) Recurrent sustained ventricular tachycardia. 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens. Circulation 58:986.
Mason, Winkle (1978) Electrode-catheter arrhythmia. Induction in the selection and assessment of antiarrhythmic drug therapy in recurrent ventricular tachycardia. Circulation 58:971.
Benditt, Gallagher, Pritchett (1978) Recurrent ventricular tachycardia in man: evaluation of antiarrhythmic drug therapy by programmed intracardiac stimulation. Management of Ventricular Tachycardia. Role of Mexiletine , E. Sandoe, D.G. Julian, J.W. Bell, Excerpta Medica, Amsterdam, Oxford; 497.